Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals

Episode 33 • September 20, 2023 • 00:26:33
Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals
Few & Far Between: How Biotech Gets Built
Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals

Sep 20 2023 | 00:26:33

/

Show Notes

View Full Transcript

Episode Transcript

"Having come from the clinical trial side, I then went to the management side. So, I understood all the problems that occur or arise when a clinical trial is being conducted - knowing what to watch out for, why the protocol is written the way it is. So that was an immense help." - Dr. Diana Sims-Silbermann Biorasi CEO, Chris O'Brien, welcomes Dr. Diana Sims-Silbermann to the latest episode of the Few & Far Between podcast. In her previous roles as a clinician and Senior Trial Manager for Janssen Pharmaceuticals, Dr. Sims-Silbermann has remained an inquisitive observer and skilled facilitator for clinical studies in Europe, with a keen understanding of regulatory requirements and patient centricity.

Other Episodes

Episode 52

April 23, 2025 • 00:52:05
Episode Cover

Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...

Listen

Episode 35

November 14, 2023 • 00:44:55
Episode Cover

Episode 35: Charlene Son Rigby, CEO at Global Genes

"And what I was really surprised about was that everybody was doing data collection in a different way. And I kept thinking that, gosh,...

Listen

Episode 1

May 18, 2021 • 00:41:00
Episode Cover

Episode 1: Paula Evans, CEO and Co-Founder of GeneTx Biotherapeutics

On today’s podcast, Jimmy El Hokayem, Head of the Neurology and Regenerative Medicine Centers of Excellence and Associate Director of Program Development at Biorasi,...

Listen